Name | malic acid, compound with 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine (1:1) |
Synonyms | 225-970-4 sanomtgran Sandomigran PIZOTIFEN MALATE Pizotifan Malate Einecs 225-970-4 Pizotifen malate PIZOTYLINE MALATE sandomygranmalate 4-(9,10-DIHYDRO-1-THIA-BENZO[F]AZULEN-4-YLIDENE)-1-METHYL-PIPERIDINE, COMPOUND WITH 2-HYDROXY-SUCCINIC ACID |
CAS | 5189-11-7 |
EINECS | 225-970-4 |
InChI | InChI=1/C19H21NS.C4H6O5/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18;5-2(4(8)9)1-3(6)7/h2-5,10,13H,6-9,11-12H2,1H3;2,5H,1H2,(H,6,7)(H,8,9) |
Molecular Formula | C23H27NO5S |
Molar Mass | 429.53 |
Melting Point | 185-186° (dec) |
Boling Point | 436.7°C at 760 mmHg |
Flash Point | 217.9°C |
Solubility | Aqueous Acid (Slightly, Heated), DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 7.92E-08mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
Storage Condition | under inert gas (nitrogen or Argon) at 2–8 °C |
Stability | Hygroscopic |
In vitro study | Pizotifen malate (BC-105 malate) is a potent 5-HT 2 receptor antagonist, with a high affinity for 5-HT 1C binding site. Pizotifen is an antidepresent 5-HT 2A receptor antagonist and has the capacity to inhibit serotonin-enhanced ADP-induced platelet aggregation. |
In vivo study | The weights of the fetuses are significantly reduced by all administered doses of Pipethiadene and Pizotifen malate (BC-105 malate) ; the weights of the placentas are significantly reduced after 0.6 and 1.2 mg/kg Pipethiadene and only after the middle dose of Pizotifen malate. The means of the implantations, live, dead fetuses, resorptions and the occurrence of external, skeletal and visceral anomalies do not differ from the control group. The number of chromosome aberrations in the bone marrow cells of treated mice does not differ significantly from the negative control group. The micronucleus test reveals no elevation in the frequency of micronuclei as compared to the control group. After the two higher doses of both Pipethiadene and Pizotifen maleate, the mitotic indices are lower than in the control group. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.328 ml | 11.641 ml | 23.281 ml |
5 mM | 0.466 ml | 2.328 ml | 4.656 ml |
10 mM | 0.233 ml | 1.164 ml | 2.328 ml |
5 mM | 0.047 ml | 0.233 ml | 0.466 ml |
biological activity | Pizotifen Malate (BC-105) is used to treat frequent migraine. |
use | this product is an antihistamine drug used to treat migraine |